Zemp Ivo, Lingner Joachim
From the Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences (SV), Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland
J Biol Chem. 2014 Oct 10;289(41):28595-606. doi: 10.1074/jbc.M114.596056. Epub 2014 Aug 29.
The telomeric shelterin component TPP1 has critical functions in telomeric protein complex assembly and telomerase recruitment and regulation. Here we identify USP7 as a novel interacting protein of the oligonucleotide/oligosaccharide-binding fold of TPP1, which was previously known to recruit telomerase to telomeres. We identify amino acids in TPP1 and USP7 that are critical for their interaction and multiple lysines within TPP1 that are oligo-ubiquitinated and deubiquitinated by USP7. Mutational analysis indicated that human TPP1 does not require ubiquitination for telomere association in contrast to previous observations reported for mouse Tpp1. Ubiquitination of human TPP1 also had no detectable effects on known protein interactions of TPP1 with TIN2, POT1, the CTC1-STN1-TEN1 complex, and telomerase. However, the close proximity of USP7 and telomerase binding sites on TPP1 suggest possible cross-talks. In addition, we found that TPP1 is degraded in a proteasome-dependent manner. Prevention of TPP1 ubiquitination prolonged TPP1 half-life ∼ 2-fold from 45 to 90 min, and remarkably, proteasome inhibition prompted complete stability of TPP1. This indicates that the proteasome destabilizes TPP1 through both direct and indirect pathways possibly involving TPP1-interacting proteins. Altogether, our work identifies novel regulatory circuits that contribute to TPP1 stability and function.
端粒保护蛋白组分TPP1在端粒蛋白复合体组装以及端粒酶募集和调控过程中发挥着关键作用。在此,我们鉴定出USP7是TPP1寡核苷酸/寡糖结合结构域的一种新型相互作用蛋白,此前已知该结构域可将端粒酶募集至端粒。我们确定了TPP1和USP7中对它们之间相互作用至关重要的氨基酸,以及TPP1内被USP7进行寡聚泛素化和去泛素化修饰的多个赖氨酸。突变分析表明,与之前报道的小鼠Tpp1不同,人类TPP1的端粒结合不需要泛素化。人类TPP1的泛素化对TPP1与TIN2、POT1、CTC1-STN1-TEN1复合体以及端粒酶之间已知的蛋白相互作用也没有可检测到的影响。然而,USP7与TPP1上的端粒酶结合位点位置相近,提示可能存在相互影响。此外,我们发现TPP1以蛋白酶体依赖的方式被降解。阻止TPP1泛素化可使TPP1的半衰期从45分钟延长约2倍至90分钟,并且值得注意的是,蛋白酶体抑制可促使TPP1完全稳定。这表明蛋白酶体通过可能涉及TPP1相互作用蛋白的直接和间接途径使TPP1不稳定。总之,我们的工作确定了有助于TPP1稳定性和功能的新型调控回路。